Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

From 2006 to 2019, age-adjusted mortality for liver disease in the US increased by 14% overall and by 24% during COVID, from 2019 through 2021.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Among patients hospitalized with severe gastrointestinal bleeding, there were low rates of diagnosis and treatment of iron deficiency anemia.

Distinct trends were seen in etiology-based mortality with chronic liver disease before, during, and after the COVID-19 pandemic.

Maternal deaths increased from 2000 to 2019, with much of the increase attributable to the pregnancy checkbox on death certificates.

Liver disease was associated with reduced protection against influenza-associated hospitalization following influenza vaccination.

The FDA has granted Orphan Drug designation to TPST-1495, dual receptor inhibitor of prostaglandin signaling, for the treatment of familial adenomatous polyposis.

Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy.